Actively Recruiting

Phase 4
Age: 12Years - 17Years
All Genders
NCT07192367

Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

Led by Emine Kanmaz · Updated on 2025-09-25

56

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

Sponsors

E

Emine Kanmaz

Lead Sponsor

K

Kocaeli University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group will receive sertraline, a commonly used medication for social anxiety. The goal is to see which treatment is more effective in reducing anxiety symptoms and improving daily functioning. The study will also look at how acceptable and safe these treatments are. A total of 56 participants will be enrolled at Kocaeli University, Department of Child and Adolescent Psychiatry.

CONDITIONS

Official Title

Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

Who Can Participate

Age: 12Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic
  • Have normal intelligence based on clinical observation
  • Be between 12 and 17 years of age
  • Have a diagnosis of social anxiety disorder (SAD)
  • Have refused medication recommended for SAD (Research arm only)
  • For SAD; not currently receiving medical treatment
  • Have received written consent to participate from self and/or authorized first-degree relatives
  • Have volunteered to participate through an invitation poster presentation
  • Accept sertraline treatment and volunteer for the study (Control arm only)
Not Eligible

You will not qualify if you...

  • Substance use disorder
  • Schizophrenia and bipolar disorder
  • Autism spectrum disorder
  • Cognitive disability
  • Neurological disorder (Research arm only)
  • Balance disorder (Research arm only)
  • Patients who have received SSRI treatment for SAD in the last 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kocaeli University Hospital - Department of Child and Adolescent Psychiatry

Kocaeli, Turkey (Türkiye), 41000

Actively Recruiting

Loading map...

Research Team

E

Emine Kayış, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here